The global Asthma Spacers Market is estimated to be valued at US$ 1.86 Bn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview
Asthma spacers are devices used with pressurized, metered-dose inhalers (MDIs) to help deliver medication to the lungs. They allow patients to inhale medication from an MDI more effectively and help reduce common errors such as exhalation into the spacer or coordinating actuations with inhalation.
Market key trends
One of the key trends in the asthma spacers market is the growing demand for portable and easy-to-use asthma spacers. With increasingly hectic lifestyles, there is demand for products that can be carried easily and used on-the-go without difficulty. This has prompted manufacturers to develop compact, lightweight asthma spacers that can be carried in bags or pockets. Integrated dose counters are another trend as they help patients track remaining doses and ensure medication adherence. Adoption of digital technologies and sensors to aid remote monitoring is also gaining ground in the market.
Segment Analysis
The global asthma spacers market has been segmented by product, disease type, distribution channel, end user, and region. By product, the market is divided into aerochamber, optichamber, volumatic, inspirae, and others. The aerochamber segment dominates the market and accounted for approximately 30% share in 2022. Aerochamber spacers are highly effective in medication delivery, economical, and helps improve medication adherence among asthma patients.
Key Takeaways
The global Asthma Spacers Market Share is expected to witness high growth, exhibiting CAGR of 6.7% over the forecast period, due to increasing prevalence of asthma worldwide. By 2030, 339 million people are expected to be suffering from asthma globally.
Regional analysis
North America dominated the global market and accounted for over 35% market share in 2022 owing to growing geriatric population, rising pollution and allergies leading to asthma, and presence of well-established healthcare facilities in the region. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to large patient population, increasing healthcare expenditure, and rising awareness about asthma management.
Key players
Key players operating in the asthma spacers market are Trudell Medical International, PARI Respiratory Equipment, Inc., Koninklijke Philips N.V, GlaxoSmithKline Plc., Lupin, Medical Developments International, Visiomed Group Ltd., Cipla Inc., Clement Clarke International Ltd., Rossmax International Ltd., Luckys Pharma, Mediacare Equipments (India) Pvt. Ltd., Asia Connection Co., Ltd., and Laboratoire Protecsom SAS.
Get More Insights On This Topic: https://www.ukwebwire.com/boost-the-growth-of-asthma-spacers-market-share-trends-analysis/
Transparency Market Research (TMR) has published a new report titled, ‘Asthma Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global asthma spacers market was valued at US$ 1,330.56 Mn in 2017 and is projected to expand at a CAGR of 3.7% during forecast period from 2018 to 2026.
The global asthma spacers market is anticipated to be driven by technological advancements and increase in use of spacers with metered dose inhalers for the management of asthma.
The asthma spacers market in Asia Pacific is expected to expand at a high CAGR of 4.2% due to high prevalence of diseases, development in the health care sector, and increase in focus on research and development.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=39410Rise in Adoption of Asthma Spacers Drives MarketInhalation is the first line administration route in asthma management.
However, poor inhalation techniques have led to poor disease control and increased health care costs.
Use of spacers/valve holding chambers minimizes issues related to the inhalation technique.
Asthma is an inflammatory disease of the airways in the lungs.
Due to swelling of the airways with certain triggers, the muscle in the airway tightens and the airway lining becomes swollen and inflamed, producing sticky mucus.The airways lining of the lungs further become narrow.
Patients feel difficulty in breathing with other typical asthma symptoms such as shortness of breath, chest tightness, wheezing, and coughing.
Generally, medication of asthma management is inhaled or breathes in, so it can go straight to your lungs where it is needed.
Some asthma medication in Australia comes in a dry powder device and a pressurised mist device.Spacers for Asthma TreatmentA spacer is a special device that looks like a clear tube and is attached to a metered-dose inhaler or puffer.
For the management of asthma symptoms, you can fire one puff of medication at a time into the spacer.
A recent study on the global Aerochamber Asthma Spacers Market has projected the revenues to rise to the worth of ~US$ 1.8 Bn by 2026 end.
The report highlights the key growth drivers and trends that will contribute to the growth momentum of the market.
It provides a comprehensive insight into the shares and sizes of the various segments in each year of the forecast period.
The assessment of the growth dynamics in the Asthma Spacers market cover the year-over-year growth of key geographies, and the incremental opportunities in numerous key countries.
A comprehensive evaluation of recent investments by top players in the Asthma Spacers market helps identify major research and development initiatives in the key regional markets.
The various assessments on the competitive landscape focus on the intensity of competition, entry barriers, PESTLE analysis, and key winning imperatives.
